Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial

Feil, Katharina; Adrion, Christine; Teufel, Julian; Boesch, Sylvia; Claassen, Jens; Giordano, Ilaria; Hengel, Holger; Jacobi, Heike; Klockgether, Thomas; Klopstock, Thomas; Nachbauer, Wolfgang; Schoels, Ludger; Stendel, Claudia; Uslar, Ellen; van de Warrenburg, Bart; Berger, Ingrid; Naumann, Ivonne; Bayer, Otmar; Mueller, Hans-Helge; Mansmann, Ulrich; Strupp, Michael

Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial

Autor(en):

Feil, Katharina; Adrion, Christine; Teufel, Julian; Boesch, Sylvia; Claassen, Jens; Giordano, Ilaria; Hengel, Holger; Jacobi, Heike; Klockgether, Thomas; Klopstock, Thomas; Nachbauer, Wolfgang; Schoels, Ludger; Stendel, Claudia; Uslar, Ellen; van de Warrenburg, Bart; Berger, Ingrid; Naumann, Ivonne; Bayer, Otmar; Mueller, Hans-Helge; Mansmann, Ulrich; Strupp, Michael

Tübinger Autor(en):

Hengel, Holger
Schöls, Ludger

Erschienen in:

BMC Neurology (2017), Bd. 17, Article 7

Verlagsangabe:

Biomed Central Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/s12883-016-0786-x

ISSN:

1471-2377
1471-2377